How long can one generally live taking the targeted drug Erdafitinib?

As for the impact of the targeted drug Erdafitinib (Erdafitinib) on patients’ lifespan, this is a complex issue because it is affected by many factors, including the patient’s individual condition, the type and characteristics of the tumor, the choice of treatment options, and the effect of treatment.

Erdafitinib is mainly studied and used to treat advanced or metastatic urothelial carcinoma (UC), which is a more malignant cancer. Targeted drugs are often used to prolong patient survival and improve quality of life.

Some patients may show a significant therapeutic response to erdafitinib, with tumor suppression and disease control, thereby prolonging survival. However, each patient's situation is unique and the effectiveness of treatment will vary from person to person.

The length of treatment is also a factor that varies from person to person. Some patients may be able to benefit from treatment with erdafitinib in the long term, while others may develop resistance or disease progression over time and require adjustments to their treatment regimen.

At the same time, in addition to drug treatment, the patient's overall health status, nutritional status, psychological state and other factors will also have an impact on life span. Supportive care and comprehensive care are also critical to patient survival and quality of life.

It is important to emphasize that cancer treatment is a complex process and each patient's response and prognosis are unique. Doctors will customize an individualized treatment plan based on the patient's specific circumstances and monitor and make adjustments throughout the treatment process.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.